Alissa Healthcare Research

Alissa Healthcare Research
01489 564069
The professional's guide to product selection
Alissa Healthcare Research
01489 564069
For the treatment of anaphylaxis and asthma.
By intravenous injection for acute hypersensitivity reactions
• Adult: 100–300 mg, to be administered as sodium succinate.
By intramuscular injection, or by intravenous injection for acute hypersensitivity r…
Antimuscarinic bronchodilator.
Reversible airway obstruction by inhalation of aerosol
• Child 1 month–5 years: 20 mcg, 3 times daily.
• Child 6–11 years: 20–40 mcg, 3 times daily.
• Over 12 years: 20–40 mcg, 3–4 times daily.
For reversible airways obstr…